Healthcare

HB 253 mandates that the Department of Public Health and Human Services (DPHHS) disclose specific health information daily during a declared public health emergency. This bill requires the DPHHS to publish on its website the total number of individuals hospitalized and those who have died due to the emergency, while adhering to confidentiality laws. For these categories, the department must provide breakdowns by age group, gender, length of hospitalization, date of death, and any contributing underlying conditions or personal characteristics. The aim is to provide the public with detailed, aggregated data about the health impacts of an emergency.

HB 41 adds gabapentin to Montana's Schedule V list of controlled substances under the "depressants" category. This change directly affects medical providers who prescribe gabapentin (used for nerve pain, seizures, and other conditions), pharmacists who dispense it, and patients using the medication. The bill amends Montana Code § 50-32-232 to explicitly include gabapentin - identified by its chemical name "1-(aminomethyl)cyclohexaneacetic acid" - in Schedule V depressants alongside drugs like pregabalin. This policy update standardizes gabapentin's regulatory classification without altering its medical use or prescribing rules.